Lyle J Arnold, Biocept's SR VP of R&D and CSO, recently acquired 50,000 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on July 06, 2016. Arnold now owns 60,714 shares of the company. Arnold operates out of San Diego, CA. Some additional info was provided as follows:
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Registration statement under Securities Act of 1933 - Aug. 18, 2017
Bin Li just provided an update on activist position in Biocept - Aug. 17, 2017
Major owner of Biocept just declared owning 3,147,667 shares of Biocept - Aug. 17, 2017
Notice of Exempt Offering of Securities, item 06b - Aug. 14, 2017
Biocept Just Filed Its Quarterly Report: 10. Net Loss per Co... - Aug. 14, 2017